Newer medications, such as Mounjaro and Wegovy, exhibit both more total weight lost and faster weight regain than older medications Montinique Monroe/Bloomberg via Getty A new analysis determined ...

How to Choose: As patients consider drugs like Wegovy, Ozempic, Zepbound and Mounjaro to treat obesity, experts say the choices are not so simple.

Novo Nordisk A/S is selling its blockbuster weight-loss drug Wegovy to new patients starting at $199 a month as easy access to cheaper copycats comes to an end. The one-time offer—available ...

Nearly 32% of Zepbound users ultimately lost at least a quarter of their body weight, compared with just 16% of Wegovy users ... the main ingredient in Mounjaro and Zepbound.

Eli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nordisk A/S’s Wegovy in the ... version of the drug, Mounjaro, is on track to ...

A trial was conducted comparing weight loss medications Zepbound and Wegovy. Results from the trial found that participants who took Zepbound lost more weight than those who took Wegovy.

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers ...

Often used as a weight-loss treatment, drugs such as Wegovy and Mounjaro have helped more than 500,000 people shed the extra pounds. The medications, known as semaglutides, predominantly treat ...

Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound treat diabetes, support weight loss The weight loss drugs differ in FDA-approved uses ...

The trial results add to the growing list of conditions that GLP-1s — the class of drugs that includes Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and Zepbound — can treat ...

Novo Nordisk has asked the Food and Drug Administration to approve Wegovy as a treatment for MASH. Eli Lilly, which makes the competitor drugs Mounjaro and Zepbound, has also studied whether the ...